BEACOPP is a chemotherapy regimen for treatment of Hodgkin lymma developed by the German Hodgkin Study Group used for patients in Stages > II or early with unfavorable risk factors. Patients typically receive treatment in cycles of 21 days with no drugs given on days 15–21.
Signup today to claim your Discount. Get Started before it's too late!
